US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

242.35

-1.3764-0.56%

Volume:2K

Turnover:588.08K

Market Cap:479.01M

PE:- -

High:242.41

Open:242.41

Low:242.26

Close:243.73

52wk High:244.35

52wk Low:160.91

Shares:1.98M

Float Shares:1.98M

Volume Ratio:0.21

T/O Rate:0.12%

Dividend:0.95

Dividend Rate:0.39%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Bernstein Remains a Hold on Revolution Medicines (RVMD)

Salesforce, UnitedHealth Share Losses Contribute to Dow's Nearly 150-Point Drop

Analysts Have Conflicting Sentiments on These Healthcare Companies: Revolution Medicines (RVMD), Royalty Pharma (RPRX) and Urogen Pharma (URGN)

Intellia Therapeutics Q2 Collaboration Revenue Falls, Net Loss Widens

Intellia Q2 FY26 Net Loss Widens to $106.63 Million; Revenue Falls to $7.66 Million

Generate Biomedicines Q2 FY26 Net Loss Widens to $67.26 Million; Revenue Drops to $6.31 Million

Revolution Medicines, Inc. : Needham Raises Target Price to $240 from $236

THOMSON REUTERS

Revolution Medicines Publishes Corporate Deck Outlining Ras(on) Inhibitor Pipeline Targeting RAS-Driven Cancers

Revolution Medicines, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Exelixis Q2 Revenue Misses Analyst Estimates, Lowers 2026 Outlook

Vir Biotechnology Q2 Revenue Up, Beats Estimates on Astellas Payment

Revolution Medicines Q2 FY26 Net Loss Widens to $644.4 Million; R&D Expenses Rise to $394.9 Million

Revolution Medicines Reports Second Quarter 2026 Financial Results and Update on Corporate Progress

THOMSON REUTERS

Gilead Sciences Declares Q3 2026 Distribution of R$ 1.42 Per Unit for Brgildbdr 000

Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Q32 Bio (QTTB)

Gilead Sciences Delivers 'Plenty' to Like in Q2, RBC Says

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Staar Surgical (STAA) and Elanco Animal Health (ELAN)

Gilead Sciences Inc Stock (GILD) Moved Down by 3.96% on Aug 5: A Full Analysis

Gilead Sciences (GILD) Faces Fresh HIV Access Criticism From AIDS Healthcare Foundation

Simply Wall St.

Amgen is Maintained at Equal-Weight by Wells Fargo

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/BBH/news?page=9"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","market":"US","secType":"STK","nameCN":"VanEck Biotech ETF","latestPrice":242.35,"timestamp":1787769075428,"preClose":243.7264,"halted":0,"volume":2426,"delay":0,"changeRate":-0.005647316006801142,"floatShares":1976503,"shares":1976503,"eps":0,"marketStatus":"Trading","change":-1.3764,"latestTime":"08-26 14:42:52 EDT","open":242.41,"high":242.41,"low":242.2645,"amount":588078.92106,"amplitude":0.000597,"askPrice":242.77,"askSize":200,"bidPrice":242.58,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787774400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":243.7264,"sharesOutstanding":1976503,"nav":240.10472,"aum":474567706.07,"dividendRate":0.003922,"bidAskSpread":0.00128,"preHourTrading":{"tag":"盘前","latestPrice":242.87,"preClose":243.7264,"latestTime":"09:29 EDT","volume":223,"amount":54165.1613,"timestamp":1787750999999,"change":-0.8564,"changeRate":-0.003514,"amplitude":0.003488},"postHourTrading":{"tag":"盘后","latestPrice":243.48,"preClose":243.7264,"latestTime":"19:30 EDT","volume":15,"amount":3655.9176,"timestamp":1787700602077,"change":-0.2464,"changeRate":-0.001011,"amplitude":0},"volumeRatio":0.208011,"impliedVol":0.2218,"impliedVolPercentile":0.8247},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBH\",,,,,undefined,":{"symbol":"BBH","floatShares":1976503,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.208011,"shares":1976503,"dividePrice":0.9505,"high":242.41,"amplitude":0.000597,"preClose":243.7264,"low":242.2645,"week52Low":160.91,"pbRate":"--","week52High":244.345,"institutionHeld":0,"latestPrice":242.35,"committee":-0.333333,"eps":0,"divideRate":0.003922,"volume":2426,"delay":0,"ttmEps":0,"open":242.41,"prevYearClose":189.2649,"prevWeekClose":241.2282,"prevMonthClose":205.5494,"prevQuarterClose":203.2373,"fiveDayClose":244.0166,"twentyDayClose":208.643,"sixtyDayClose":185.94},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBH","amount":0.9565,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-12-23","symbol":"BBH","amount":1.2517,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-23","defaultRemindTime":1734964200000,"name":"VanEck Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-24","payableDate":"2024-12-23","currency":"USD","dateTimestamp":1734930000000,"payDate":"2024-12-24"},{"date":"2023-12-18","symbol":"BBH","amount":0.7127,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"VanEck Biotech ETF","recordDate":"2023-12-22","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-22"},{"market":"US","date":"2022-12-19","symbol":"BBH","amount":0.7488,"defaultRemindTime":1671460200000,"name":"VanEck Biotech ETF","recordDate":"2022-12-23","payableDate":"2022-12-20","currency":"USD","type":"dividend","dateTimestamp":1671426000000},{"market":"US","date":"2021-12-20","symbol":"BBH","amount":0.3972,"defaultRemindTime":1640010600000,"name":"VanEck Vectors Biotech ETF","recordDate":"2021-12-27","payableDate":"2021-12-21","currency":"USD","type":"dividend","dateTimestamp":1639976400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBH\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-19","recordDate":"2016-12-21","paymentDate":"2016-12-23","value":0.327,"currency":"USD"},{"executeDate":"2018-12-20","recordDate":"2018-12-21","paymentDate":"2018-12-27","value":0.006,"currency":"USD"},{"executeDate":"2019-12-23","recordDate":"2019-12-24","paymentDate":"2019-12-30","value":0.4724,"currency":"USD"},{"executeDate":"2020-12-21","recordDate":"2020-12-22","paymentDate":"2020-12-28","value":0.6079,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-27","value":0.3972,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBH\",pageSize:20,pageCount:9,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657658768","title":"Bernstein Remains a Hold on Revolution Medicines (RVMD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657658768","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657658768?lang=en_us&edition=fundamental","pubTime":"2026-08-06 23:01","pubTimestamp":1786028493,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Jeffrey Walch from Bernstein maintained a Hold rating on Revolution Medicines, with a price target of $151.00. Walc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-hold-on-revolution-medicines-rvmd-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-hold-on-revolution-medicines-rvmd-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BJT1NW94.SGD","LU0889565916.HKD","IE0002141913.USD","IE0009354923.USD","IDNA","LU0109394709.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","CANC","IE00B4R5TH58.HKD","BBH","LU0320765992.SGD","RVMD","PTH","BK4139","IE00BFTCPJ56.SGD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657585496","title":"Salesforce, UnitedHealth Share Losses Contribute to Dow's Nearly 150-Point Drop","url":"https://stock-news.laohu8.com/highlight/detail?id=2657585496","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657585496?lang=en_us&edition=fundamental","pubTime":"2026-08-06 22:46","pubTimestamp":1786027560,"startTime":"0","endTime":"0","summary":"DJ Salesforce, UnitedHealth Share Losses Contribute To Dow's Nearly 150-Point DropThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Salesforce and UnitedHealth are seeing declines Thursday morning, dragging the Dow Jones Industrial Average into negative territory.Shares of Salesforce  and UnitedHealth  have contributed to the blue-chip gauge's intraday decline, as the Dow  was most recently trading 144 points lower .Salesforce's shares have fallen $6.53  while those of UnitedHealth have declined $6.27, or 1.5%, combining for a roughly 76-point drag on the Dow.Also contributing significantly to the decline are Boeing , Honeywell , and Amgen .A $1 move in any of the Dow's 30 components equates to a 5.94-point swing.Data source: Dow Jones Market Data, FactSet. Data compiled August 6, 2026.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0545039389.USD","SG9999017495.SGD","UNH","LU2326559502.SGD","LU0683600562.USD","LU1003077747.HKD","LU2491049909.HKD","LU0069063385.USD","LU0316494557.USD","LU2362540622.SGD","LU1732799900.SGD","TRUH","BK4154","BK4534","LU0648001328.SGD","LU0976567544.SGD","BIB","IE0002270589.USD","LU2324357040.USD","LU2286300806.USD","LU1316542783.SGD","IE00B894F039.SGD","LU2242649171.HKD","LU0058720904.USD","BOEG","LU2461242641.AUD","LU1934455194.USD","LU0211328371.USD","LU0353189680.USD","LU0557290698.USD","FHLC","SG9999018865.SGD","LU0689472784.USD","LU1804176565.USD","LU0310799852.SGD","SG9999014914.USD","PPA","LU0234570918.USD","IE00BKVL7J92.USD","LU1923623000.USD","LU0072461881.USD","LU0158827781.USD","LU0965509101.SGD","LU2244417387.USD","BK4023","BK4579","LU2279689827.SGD","LU1074936037.SGD","LU0109391861.USD","LU0354030438.USD","LU2242652126.USD","IE00BQXX3D17.EUR","PBE","BK4206","BK4527","IBB","IE00B2B36J28.USD","BK4599","LU2265009873.SGD","IE00B7KXQ091.USD","LU0052756011.USD","LU1046421795.USD","LU0980610538.SGD","BBH","LU0053666078.USD","LU1803068979.SGD","LU0048573561.USD","LU2491050154.USD","LU2999663052.SGD","LU2954938101.SGD","LU0496365809.HKD","LU0251131958.USD","LU1066051225.USD","LU0143551892.USD","LU0648000940.SGD","BK4607","TBXU","LU1037948541.HKD","LU1791710582.SGD","IYH","IE0004445015.USD","LU0795875169.SGD","LU1551013342.USD","LU1023059063.AUD","LU2756315318.SGD","LU0511384066.AUD","UNHW","LU0029864427.USD","IE00BFSS7M15.SGD","HRTS","LU1066051498.USD","LU0128525689.USD","LU0342679015.USD","LU0097036916.USD","MHIP","LU0128525929.USD","LU0109394709.USD","IE00BN29S564.USD","LU0289739343.SGD","LU1854103824.USD","LU0320765992.SGD","LU0820561818.USD","LU1674673691.USD","LU1934455277.USD","BK4602","SG9999014898.SGD","LU0868494617.USD","LU1934455863.HKD","LU2125154935.USD","SG9999002224.SGD","IE00BFXG1179.USD","LU0157215616.USD","IE00B775H168.HKD","LU1267930227.SGD","BK4598","SG9999018857.SGD","IE00BSNM7G36.USD","LU0077335932.USD","LU1064131342.USD","LU0094547139.USD","LU1670628061.USD","LU0314104364.USD","LU1989771016.USD","LU0472753341.HKD","LU2264538146.SGD","NATO","LU2236285917.USD","BK4564","LU1084165304.USD","LU0965508806.USD","LU1823568750.SGD","LU0251132253.USD","LU0868494708.USD","IE00B19Z9P08.USD","IE00B4JS1V06.HKD","LU1035773651.USD","AMGN","LU0107464264.USD","LU0528227936.USD","IE00B19Z3581.USD","LU1914381329.SGD","IE00B19Z8W00.USD","BK4561","LU0320765059.SGD","LU0738911758.USD","BK4538","IE00BJJMRY28.SGD","BK4581","LU0106261372.USD","LU0965509283.SGD","LU0310800379.SGD","LU2023251221.USD","LU0130103400.USD","IE00BFSS8Q28.SGD","LU1983299246.USD","LU1323610961.USD","LU0149725797.USD","IDEF","BK4566","LU1496350171.SGD","LU1988902786.USD","IE00B3T34201.USD","LU1429558221.USD","JDOC","IE0004445239.USD","IE00B19Z3B42.SGD","SG9999001176.SGD","LU2211815571.USD","LU0354030511.USD","LU0689626769.HKD","LU1119994496.HKD","LU0203347892.USD","IE0002141913.USD","LU1718418525.SGD","LU1496350502.SGD","LU2089984988.USD","LU1670627923.USD","LU0109392836.USD","LU0942090050.USD","IBBQ","LU0787776722.HKD","LU1435385759.SGD","IE00BQXX3C00.GBP","IE0034235188.USD","LU0187121727.USD","LU1548497426.USD","BK4567","LU0289739699.SGD","LU0162691827.USD","LU2112291526.USD","LU0211327993.USD","LU1989764664.SGD","BA","LU0477156797.USD","IE000M9KFDE8.USD","LU0965509010.AUD","LU0820562030.AUD","LU0708994859.HKD","IE00BZ9MQY76.HKD","LU1069347547.HKD","BK4548","LU0345770308.USD","LU1057294990.SGD","LU2271345857.HKD","LU0943347566.SGD","LU0792757196.USD","LU1571399168.USD","IHF","CRMG","LU1291159041.SGD","LU1066053197.SGD","BK4588","BK4139","LU1506573853.SGD","LU2360032135.SGD","LU0672654240.SGD","LU0719512351.SGD","LU0642271901.SGD","04332","IE00BJJMRZ35.SGD","LU2028103732.USD","LU1061106388.HKD","LU0079474960.USD","LU2111349929.HKD","BK4585","GDOC","LU0203345920.USD","SG9999014880.SGD","SGXZ57979304.SGD","FOWF","IE00BFTCPJ56.SGD","BK4543","IE00BJJMRX11.SGD","SG9999001176.USD","LU0114720955.EUR","LU1267930573.SGD","LU1267930490.SGD","BK4613","BK4551","LU0661504455.SGD","LU0251142724.SGD","LU2756315664.SGD","LU0477156953.USD","LU0708995401.HKD","HON","LU1235294995.USD","SGXZ51526630.SGD","LU1201861249.SGD","LU0211326755.USD","LU0889565833.HKD","IE0009355771.USD","LU0742534661.SGD","UNHG","SG9999001440.SGD","LU2133065610.SGD","LU0823416689.USD","LU2552382058.USD","LU0353189763.USD","IE0005OL40V9.USD","LU0081259029.USD","ITA","IE00B19Z9505.USD","IE00B4R5TH58.HKD","IE00B19Z9Z06.USD","VHT","LU0266013472.USD","IE00B1BXHZ80.USD","LU2087625088.SGD","LU0889565916.HKD","LU1951198990.SGD","LU2361044865.SGD","CRM","LU0456855351.SGD","IE00B1XK9C88.USD","LU1261432733.SGD","BK4533","LU2361044949.HKD","LU1989764748.USD","LU0267386448.USD","LU0310800965.SGD","SG9999002232.USD","LU1267930730.SGD","BK4528","BK4505","LU1732800096.USD","LU0130518102.USD","RXL","LU2247934214.USD","SGXZ99366536.SGD","LU2552382132.HKD","PJP","LU0820561909.HKD","BK4516","SGXZ31699556.SGD","LU0130102774.USD","LU0158827948.USD","LU0127658192.USD","LU0198837287.USD","LU1720051017.SGD","LU2458330243.SGD","LU2089283258.USD","LU0949170772.SGD","LU1551013425.SGD","LU1201861165.SGD","UNHU","LU1066051811.HKD","LU2347655156.SGD","LU2242646821.SGD","LU0553294199.USD","LU0289961442.SGD","IE00BZ1G4Q59.USD","LU0256863811.USD","TMED","LU2361045086.USD","LU1854104046.USD","BK4532","IE00B7SZLL34.SGD","LU1366333091.USD","LU1674673428.USD","LU2357305700.SGD","LU2362541513.USD","LU1791710400.SGD","LU0345770993.USD","LU0124676726.USD","BK4535","IE00BKPKM429.USD","BOEU","LU0211326839.USD","IXJ","MISL","IE00B19Z8X17.USD","LU0861579265.USD","SG9999014906.USD","LU0057025933.USD","IE00BWXC8680.SGD","LU0006306889.USD","IE00BJTD4V19.USD","IE00BJT1NW94.SGD","BK4550","IE00BJTD4N35.SGD","LU2362541273.HKD","LU0417517546.SGD","LU1951200564.SGD","LU2491050071.SGD","LU1778281490.HKD","LU0082616367.USD","LU1814569148.SGD","BK4608","LU1267930813.SGD","LU0432979614.USD","LU0130517989.USD","SGXZ81514606.USD","LU2458330169.SGD","LU2468319806.SGD","XLV","LU0122379950.USD","LU0889566641.SGD","IE00BQXX3F31.USD","LU0238689110.USD","BK4187","BOED","LU1037948897.HKD","LU0234572021.USD","LU2125154778.USD","LU0048584097.USD","SG9999013999.USD","LU2552382215.SGD","LU0912757837.SGD","LU1153585028.USD","LU1720051108.HKD","LU0882574055.USD","LU2089284900.SGD","LU0011850046.USD","LU0795875086.SGD","LU2462591277.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657639266","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Revolution Medicines (RVMD), Royalty Pharma (RPRX) and Urogen Pharma (URGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657639266","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657639266?lang=en_us&edition=fundamental","pubTime":"2026-08-06 20:10","pubTimestamp":1786018244,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Revolution Medicines (RVMD), Royalty Pharma (RPRX) and Urogen Pha...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-revolution-medicines-rvmd-royalty-pharma-rprx-and-urogen-pharma-urgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-revolution-medicines-rvmd-royalty-pharma-rprx-and-urogen-pharma-urgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4007","CANC","PTH","LU0128526141.USD","BBH","RVMD","IHE","LU0889565916.HKD","XBI","IE00BJJMRZ35.SGD","BK4137","IE0002141913.USD","RPRX","LU0320765992.SGD","URGN","XLV","LABU","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","BK4139","IE00BJT1NW94.SGD","BK4581","IDNA","IE0009355771.USD","BK4585","PBE","LU0109394709.USD","BK4588","HCSG","IE00B2B36J28.USD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657560633","title":"Intellia Therapeutics Q2 Collaboration Revenue Falls, Net Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2657560633","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657560633?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:20","pubTimestamp":1786015252,"startTime":"0","endTime":"0","summary":"Intellia Therapeutics Q2 collaboration revenue falls, net loss widensOverviewU.S. gene editing firm's Q2 collaboration revenue fell yr/yr due to lower Regeneron revenueQ2 net loss widened from prior y","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4430JC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","CRSP","LU2468319806.SGD","LU0320765992.SGD","LU0114720955.EUR","PGEN","TBXU","IBB","LU2023250504.SGD","LU0823434740.USD","LU0823434583.USD","NTLA","LU1861559042.SGD","LU1917777945.USD","LU1974910355.USD","LU0058720904.USD","BK4585","IBBQ","BK4588","BK4611","LU2237438978.USD","LU2362541273.HKD","BK4556","BBH","EDIT","LU0823416689.USD","LU0889565916.HKD","LU0882574055.USD","REGN","LU2106854487.HKD","LU2362541513.USD","LU0289739699.SGD","LU2362540622.SGD","BK4535","BK4139","ARKG","LU0109394709.USD","LU1861558580.USD","LU0053666078.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657638109","title":"Intellia Q2 FY26 Net Loss Widens to $106.63 Million; Revenue Falls to $7.66 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657638109","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657638109?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:09","pubTimestamp":1786014575,"startTime":"0","endTime":"0","summary":"Intellia Q2 FY26 net loss widens to $106.63 million; revenue falls to $7.66 millionIntellia posted a GAAP net loss of USD 106.63 million, widening from USD 101.26 million a year earlier; loss per shar","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL3QMBnk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","LU2237438978.USD","LU0053666078.USD","NTLA","LU2023250504.SGD","LU0823434740.USD","REGN","LU0823416689.USD","LU2089984988.USD","LU0109394709.USD","LU2362541273.HKD","LU0823434583.USD","LU0058720904.USD","LU1861558580.USD","LU1861559042.SGD","LU0889565916.HKD","LU1974910355.USD","LU2468319806.SGD","BK4556","LU0320765992.SGD","LU0114720955.EUR","BK4535","LU0882574055.USD","LU1917777945.USD","LU0289739699.SGD","BK4585","LU2362540622.SGD","IBBQ","LU2106854487.HKD","TBXU","BBH","IBB","LU2362541513.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657682336","title":"Generate Biomedicines Q2 FY26 Net Loss Widens to $67.26 Million; Revenue Drops to $6.31 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657682336","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657682336?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:11","pubTimestamp":1786011111,"startTime":"0","endTime":"0","summary":"Generate Biomedicines Q2 FY26 net loss widens to $67.26 million; revenue drops to $6.31 millionGenerate Biomedicines posted a GAAP net loss of $67.26 million for the quarter ended June 30, 2026, widen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL8LfD7q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","IE00BJT1NW94.SGD","LU0289739699.SGD","IBB","LU1057294990.SGD","LU2242646821.SGD","TBXU","LU1571399168.USD","BK4534","SG9999001440.SGD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","LU0320765992.SGD","LU0889565916.HKD","IE0002141913.USD","LU2242652126.USD","BK4599","BIB","LU0868494617.USD","IE00B4R5TH58.HKD","IE0009355771.USD","LU2089984988.USD","IE00BFTCPJ56.SGD","BBH","BK4566","BK4581","AMGN","LU1983299246.USD","PJP","PBE","BK4585","LU2112291526.USD","LU0058720904.USD","IBBQ","BK4533","LU1061106388.HKD","BK4139","LU1023059063.AUD","BK4588","LU0109394709.USD","LU0122379950.USD","GENB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657899596","title":"Revolution Medicines, Inc. : Needham Raises Target Price to $240 from $236","url":"https://stock-news.laohu8.com/highlight/detail?id=2657899596","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657899596?lang=en_us&edition=fundamental","pubTime":"2026-08-06 17:10","pubTimestamp":1786007401,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN44313L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RVMD","IE00BFTCPJ56.SGD","PTH","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","IE00BJJMRZ35.SGD","IE0002141913.USD","IE00BJT1NW94.SGD","BBH","IE0009354923.USD","IE0009355771.USD","IE00B4R5TH58.HKD","IDNA","CANC","BK4139","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657571976","title":"Revolution Medicines Publishes Corporate Deck Outlining Ras(on) Inhibitor Pipeline Targeting RAS-Driven Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2657571976","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657571976?lang=en_us&edition=fundamental","pubTime":"2026-08-06 06:01","pubTimestamp":1785967310,"startTime":"0","endTime":"0","summary":"Revolution Medicines publishes corporate deck outlining RAS(ON) inhibitor pipeline targeting RAS-driven cancersRevolution Medicines highlighted Phase 3 RASolute 302 data in previously treated metastat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL65Wkg4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","IE00BFTCPJ56.SGD","RVMD","CANC","IE00B4R5TH58.HKD","PTH","IE0002141913.USD","BK4139","IE0009354923.USD","LU0889565916.HKD","IDNA","IE00B2B36J28.USD","IE00BJT1NW94.SGD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657576322","title":"Revolution Medicines, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657576322","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657576322?lang=en_us&edition=fundamental","pubTime":"2026-08-06 05:01","pubTimestamp":1785963706,"startTime":"0","endTime":"0","summary":"Revolution Medicines, Inc. reports results for the quarter ended June 30 - Earnings SummaryRevolution Medicines, Inc.RVMD.OQreported a quarterly adjusted loss of $3.06 per share for the quarter ended ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL8N4423HO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","IE00BJJMRZ35.SGD","IDNA","IE00BJT1NW94.SGD","PTH","RVMD","IE00B2B36J28.USD","CANC","IE00B4R5TH58.HKD","LU0320765992.SGD","BK4139","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","IE0002141913.USD","LU0889565916.HKD","BBH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657357543","title":"Exelixis Q2 Revenue Misses Analyst Estimates, Lowers 2026 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2657357543","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657357543?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:53","pubTimestamp":1785963209,"startTime":"0","endTime":"0","summary":"Exelixis Q2 revenue misses analyst estimates, lowers 2026 outlookOverviewU.S. oncology firm's Q2 revenue rose yr/yr but missed analyst expectationsAdjusted net income for Q2 beat analyst estimatesComp","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4421EH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","LU2468319806.SGD","LU0122379950.USD","LU2089984988.USD","LU2242652126.USD","IE00B4R5TH58.HKD","LU2242646821.SGD","URGN","LU1571399168.USD","BK4534","IE0002141913.USD","BK4581","IE0009355771.USD","BK4588","IE00BJJMRZ35.SGD","LU1057294990.SGD","PBE","PJP","TBXU","BIB","LU0289739699.SGD","LU1061106388.HKD","LU0109394709.USD","BK4139","BK4585","EXEL","LU1023059063.AUD","LU0868494617.USD","IBB","AMGN","LU0058720904.USD","IBBQ","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","BK4566","BK4533","LU2112291526.USD","BK4599","IE00BJT1NW94.SGD","LU0320765992.SGD","SG9999001440.SGD","BBH","LU1983299246.USD","BK4532"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657578623","title":"Vir Biotechnology Q2 Revenue Up, Beats Estimates on Astellas Payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2657578623","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657578623?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:20","pubTimestamp":1785961240,"startTime":"0","endTime":"0","summary":"Vir Biotechnology Q2 revenue up, beats estimates on Astellas paymentOverviewU.S. biopharma's Q2 revenue rose sharply, beating analyst expectationsQ2 net income was $80.1 mln, reversing a net loss last","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL1N4421BR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","BIB","IE00B19Z3B42.SGD","LU1983299246.USD","GILD","IE00BJJMRZ35.SGD","LU0882574055.USD","BK4550","LU0058720904.USD","IE00B4R5TH58.HKD","LU0234570918.USD","LU1674673691.USD","BK4535","AMGN","LU0114720955.EUR","LU0823416689.USD","LU1066051498.USD","LU2087621335.USD","LU1571399168.USD","IE00BSNM7G36.USD","BK4599","LU0861579265.USD","MEDI","KYMR","TBXU","PJP","LU1061106388.HKD","LU0889565916.HKD","PBE","LU1839511570.USD","LU1934455863.HKD","LU0289739699.SGD","BK4532","IBBQ","IBB","LU0965509101.SGD","BK4568","SG9999015978.USD","LU1430594728.SGD","SG9999015945.SGD","IE0002270589.USD","LU1057294990.SGD","TMED","LU0868494617.USD","VIR","IE00B3T34201.USD","BBH","LU1585245621.USD","BMED","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657057882","title":"Revolution Medicines Q2 FY26 Net Loss Widens to $644.4 Million; R&D Expenses Rise to $394.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2657057882","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657057882?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:17","pubTimestamp":1785961029,"startTime":"0","endTime":"0","summary":"Revolution Medicines Q2 FY26 net loss widens to $644.4 million; R&D expenses rise to $394.9 millionRevolution Medicines posted a GAAP net loss of $644.4 million for Q2 2026, widening from a $247.8 mil","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL46m7gf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210149790.SGD","PTH","IE00BKPKM429.USD","IE0009355771.USD","RPRX","LU0889565916.HKD","BK4112","BCDF","CANC","IE00B3QW5Z07.USD","BK4588","IE00BGHQF748.EUR","LU2095319765.USD","LU2210150020.SGD","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","IE00BFTCPJ56.SGD","LU0109394709.USD","IE00BJT1NW94.SGD","NDAQ","LU0320765992.SGD","PBE","BBH","IE00B2B36J28.USD","IE00BN0W2W23.USD","SG9999014039.USD","BK4007","IHE","LU0314104364.USD","SG9999014013.SGD","BK4139","IE0002141913.USD","SG9999014021.USD","IDNA","IE0009354923.USD","SG9999014005.SGD","BK4585","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","RVMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657527610","title":"Revolution Medicines Reports Second Quarter 2026 Financial Results and Update on Corporate Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2657527610","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657527610?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:02","pubTimestamp":1785960120,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nTUA9FY8WX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RVMD","LU0320765992.SGD","IE00BJJMRZ35.SGD","IE0009354923.USD","LU0889565916.HKD","IE00BFTCPJ56.SGD","IDNA","BBH","CANC","IE00BJT1NW94.SGD","BK4139","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE0002141913.USD","LU0109394709.USD","PTH","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657224905","title":"Gilead Sciences Declares Q3 2026 Distribution of R$ 1.42 Per Unit for Brgildbdr 000","url":"https://stock-news.laohu8.com/highlight/detail?id=2657224905","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657224905?lang=en_us&edition=fundamental","pubTime":"2026-08-06 03:36","pubTimestamp":1785958615,"startTime":"0","endTime":"0","summary":"Gilead Sciences declares Q3 2026 distribution of R$ 1.42 per unit for BRGILDBDR 000Gilead declared a 3Q 2026 cash distribution of R$ 1.42 per unit for ISIN BRGILDBDR000.Shares trade with entitlement t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nNDL34j8pX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","LU1037948897.HKD","BBH","MEDI","IBBQ","SG9999015978.USD","LU0965509101.SGD","LU0320765992.SGD","BK4566","IE00B3T34201.USD","LU1674673428.USD","LU1778281490.HKD","TBXU","IE00B7SZLL34.SGD","BMED","IE00BZ1G4Q59.USD","LU0889565916.HKD","LU2468319806.SGD","BK4568","BIB","IE0002270589.USD","LU1061106388.HKD","LU0234570918.USD","LU1585245621.USD","LU1037948541.HKD","SG9999015952.SGD","LU0882574055.USD","LU0965509283.SGD","LU1934455863.HKD","LU1057294990.SGD","BK4583","LU0289739699.SGD","LU1674673691.USD","LU1839511570.USD","LU2089984988.USD","SG9999015986.USD","LU0823416689.USD","IE00BKVL7J92.USD","BK4532","LU2112291526.USD","LU0122379950.USD","TMED","GILD","LU0114720955.EUR","IBB","LU2324357040.USD","IE00B19Z3581.USD","LU0109394709.USD","IE00B19Z3B42.SGD","LU1934455194.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657524750","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX) and Q32 Bio (QTTB)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657524750","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657524750?lang=en_us&edition=fundamental","pubTime":"2026-08-06 02:30","pubTimestamp":1785954614,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Vertex Pharmaceuticals (VRTX) and Q32 Bio (QTTB) wit...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-and-q32-bio-qttb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-and-q32-bio-qttb-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","BK4588","LU0417517546.SGD","LU0079474960.USD","IE00B2B36J28.USD","BK4581","LU1093756168.USD","BK4023","LU2462157665.USD","LU1430594728.SGD","LU0256863811.USD","IE00B19Z9Z06.USD","LABU","LU1093756325.SGD","LU0823416689.USD","SG9999001176.USD","GNMX","LU2089984988.USD","LU0109394709.USD","LU2362541273.HKD","LU1585245621.USD","IE00B19Z3581.USD","IE00BJT1NW94.SGD","XLV","SG9999001176.SGD","LU0889565916.HKD","IE00B19Z9P08.USD","LU2468319806.SGD","BK4532","HCSG","IE00B19Z3B42.SGD","LU1069344957.HKD","LU0289739699.SGD","IDNA","VRTX","BIB","IBBQ","LU2417539215.USD","IE00BFTCPJ56.SGD","XBI","LU1815336091.USD","LU0061475181.USD","SGXZ57979304.SGD","TBXU","QTTB","VERX","BBH","PBE","IBB","LU2362541513.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657521560","title":"Gilead Sciences Delivers 'Plenty' to Like in Q2, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2657521560","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657521560?lang=en_us&edition=fundamental","pubTime":"2026-08-06 01:17","pubTimestamp":1785950227,"startTime":"0","endTime":"0","summary":"Gilead Sciences  offered \"plenty\" to like in Q2, with strong HIV performance more than offsetting slower franchises, RBC said in a note Tuesday.The report said it should be well received that the higher HIV growth guidance helped drive the incremental full-year product sales guidance raise, reflecting expectations for steadying volume dynamics and favorable pricing pull through.Still, the note pointed to some modest long-term headwinds, including the Inflation Reduction Act and a more fragmented HIV market with more switch options.But its strong operational performance sets a higher base into any potential erosion, and the company has multiple shots to continue dominance, the note added.The report said sentiment may lean positive and keep shares at optimistic levels as its near-term performance is expected to remain solid amid \"palatable\" forward multiple.RBC raised its price target to $123 from $120 while maintaining its sector perform rating.Price: 130.80, Change: -4.45, Percent Chan","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BIB","LU0965508806.USD","LU2089984988.USD","LU0320765992.SGD","LU0114720955.EUR","LU1023059063.AUD","TBXU","LU1057294990.SGD","IE00B19Z3581.USD","IBB","SG9999015986.USD","SG9999015945.SGD","LU2112291526.USD","LU1674673428.USD","BK4532","LU1037948541.HKD","LU1061106388.HKD","LU1066051498.USD","IE00B3T34201.USD","IE00BKVL7J92.USD","GILD","BK4583","LU0058720904.USD","BK4585","IBBQ","LU0965509283.SGD","LU2087621335.USD","SG9999015978.USD","LU1585245621.USD","BK4578","BMED","BBH","LU0823416689.USD","LU0889565916.HKD","MEDI","LU1778281490.HKD","IE0002270589.USD","LU0861579265.USD","LU0289739699.SGD","LU1037948897.HKD","LU1066053197.SGD","LU1571399168.USD","LU1934455277.USD","TMED","BK4139","LU0109394709.USD","LU0965509010.AUD","IE00BSNM7G36.USD","IE00B7SZLL34.SGD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657529938","title":"Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD), Staar Surgical (STAA) and Elanco Animal Health (ELAN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657529938","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657529938?lang=en_us&edition=fundamental","pubTime":"2026-08-06 00:30","pubTimestamp":1785947427,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Gilead Sciences (GILD), Staar Surgical (STAA) and El...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-gilead-sciences-gild-staar-surgical-staa-and-elanco-animal-health-elan-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-gilead-sciences-gild-staar-surgical-staa-and-elanco-animal-health-elan-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","LU2324357040.USD","ELAN","LU1023059063.AUD","XBI","IBB","IE00BZ1G4Q59.USD","LU0882574055.USD","LU1941712348.USD","LU1934455863.HKD","LU0289739699.SGD","STAA","IE00B3T34201.USD","BK4581","LU0234570918.USD","BIB","BMED","LU0320765992.SGD","BK4137","TMED","LU1839511570.USD","IBBQ","XLV","BK4198","BBH","LU1430594728.SGD","IE00BKVL7J92.USD","SG9999015986.USD","LU1585245621.USD","TBXU","LU1941712264.USD","BK4139","LU2468319806.SGD","BK4568","LU0965509101.SGD","LU1061106388.HKD","LU2112291526.USD","LU2087621335.USD","LU0823416689.USD","BK4588","LU0965509283.SGD","GILD","LU0058720904.USD","HCSG","LU0861579265.USD","MEDI","LU1674673691.USD","SG9999015952.SGD","LABU","IE0002270589.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657529829","title":"Gilead Sciences Inc Stock (GILD) Moved Down by 3.96% on Aug 5: A Full Analysis","url":"https://stock-news.laohu8.com/highlight/detail?id=2657529829","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657529829?lang=en_us&edition=fundamental","pubTime":"2026-08-06 00:15","pubTimestamp":1785946529,"startTime":"0","endTime":"0","summary":"• Gilead Sciences shares fell after lowering its full-year earnings guidance.\n• Decelerating HIV franchise sales and lackluster oncology clinical results impacted investor sentiment.\n• Increased operational and research costs compressed the company's profit margins.","market":"nz","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262078657-market-movers-gild-20260805","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","LU1037948897.HKD","BBH","MEDI","IBBQ","SG9999015978.USD","LU0965509101.SGD","LU1023059063.AUD","LU0320765992.SGD","BK4566","IE00B3T34201.USD","LU1674673428.USD","LU1778281490.HKD","TBXU","IE00B7SZLL34.SGD","BMED","IE00BZ1G4Q59.USD","LU0889565916.HKD","LU1066053197.SGD","LU2468319806.SGD","LU1571399168.USD","BK4568","BIB","IE0002270589.USD","LU1061106388.HKD","LU0234570918.USD","LU2087621335.USD","LU0861579265.USD","LU1585245621.USD","BK4588","LU1037948541.HKD","BK4578","LU1430594728.SGD","SG9999015952.SGD","BK4585","LU0882574055.USD","LU0965509010.AUD","LU0965509283.SGD","LU0965508806.USD","LU1934455863.HKD","LU1057294990.SGD","BK4583","LU0289739699.SGD","LU1674673691.USD","LU1839511570.USD","LU2089984988.USD","SG9999015986.USD","LU0823416689.USD","IE00BKVL7J92.USD","BK4532","LU0058720904.USD","LU0122379950.USD","LU2112291526.USD","LU1066051498.USD","TMED","GILD","LU1934455277.USD","LU0114720955.EUR","IBB","BK4139","LU1934455194.USD","IE00B19Z3581.USD","LU2324357040.USD","LU0109394709.USD","IE00B19Z3B42.SGD","BK4550","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657299215","title":"Gilead Sciences (GILD) Faces Fresh HIV Access Criticism From AIDS Healthcare Foundation","url":"https://stock-news.laohu8.com/highlight/detail?id=2657299215","media":"Simply Wall St.","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657299215?lang=en_us&edition=fundamental","pubTime":"2026-08-05 23:23","pubTimestamp":1785943407,"startTime":"0","endTime":"0","summary":"AIDS Healthcare Foundation publicly criticizes Gilead Sciences (NasdaqGS:GILD) for high profits and restrictive access to affordable HIV treatments in low and middle income countries.\nThe group accuses the company of limiting global access to lower cost medication options, renewing scrutiny on HIV drug pricing and licensing practices.\nThe criticism highlights ongoing concerns around global health equity and the role of large pharmaceutical companies in supporting access to essential...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-sciences-gild-faces-fresh-hiv-access-criticism-from-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-sciences-gild-faces-fresh-hiv-access-criticism-from-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IE00BSNM7G36.USD","LABU","LU0965509101.SGD","LU2089984988.USD","BK4532","BK4550","IBB","LU1066053197.SGD","LU1934455194.USD","BBH","SG9999015986.USD","LU0289739699.SGD","LU0861579265.USD","LU1066051498.USD","BK4588","BK4137","LU0128526141.USD","LU0234570918.USD","LU0889565916.HKD","LU2468319806.SGD","LU1037948897.HKD","BIB","IE00BZ1G4Q59.USD","LU0965508806.USD","LU1057294990.SGD","IE00B19Z3581.USD","XLV","HCSG","BK4566","SG9999015952.SGD","TMED","LU0109394709.USD","IE00B7SZLL34.SGD","IBBQ","GILD","LU1023059063.AUD","LU0320765992.SGD","MEDI","BK4581","XBI","BMED","BK4583","VIG","LU0114720955.EUR","LU2324357040.USD","LU0965509283.SGD","TBXU","LU1571399168.USD","LU0965509010.AUD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657652560","title":"Amgen is Maintained at Equal-Weight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2657652560","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657652560?lang=en_us&edition=fundamental","pubTime":"2026-08-05 23:03","pubTimestamp":1785942180,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/AMGN/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TFNS","LU0109394709.USD","LU0130517989.USD","LU1023059063.AUD","LU2242646821.SGD","LU0314106906.USD","IBB","LU0868494708.USD","LU0130102774.USD","BIB","LU2236285917.USD","LU0289960550.SGD","LU1894683348.USD","LU0320765992.SGD","PGF","BK4533","LU1074936037.SGD","LU1506573853.SGD","IBBQ","LU0211328371.USD","BBH","KBWB","LU0211327993.USD","LU1267930573.SGD","TBXU","PJP","BK4139","LU2089984988.USD","LU0889565916.HKD","LU0640476718.USD","LU0417517546.SGD","IE000M9KFDE8.USD","LU0251142724.SGD","LU0149725797.USD","PBE","BK4588","IYF","IE00B2B36J28.USD","LU0251131958.USD","LU0868494617.USD","LU2361044949.HKD","LU0256863811.USD","LU2242652126.USD","IE0002141913.USD","LU1201861249.SGD","FTXO","AMGN","IE00B19Z3B42.SGD","LU1571399168.USD","LU1035773651.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}]}}